Manufacturer record

Tirupati Medicare Limited: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Tirupati Medicare Limited (Himachal Pradesh) were declared Not of Standard Quality between September 2022 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

4 records linked to Tirupati Medicare Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Sep 2022 to Feb 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2022
3
Products affected
Dissolution
Most common failure
Feb 2026
Latest alert

Flagged batches per year

2022 · 12023 · 12024 · 12026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Cholecalciferol Tablets 60,000 IU NGT25007Mfg 2025-08 · Exp 2027-01 The contents of Cholecalciferol found to be 90585.84 I.U(150.97%)labeled claim of 60000 I.U per UC tab.Labelling SDTL, PunjabState lab Feb 2026
Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP (Montas- L) MAT22030Mfg 2022-06 · Exp 2024-05 Dissolution of MontelukastDissolution RDTL GuwahatiState lab Feb 2024
Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP (Montzer-C) MTZ2200 3Mfg 2022-12 · Exp 2024-11 Dissolution of MontelukastDissolution CDL KolkataCDSCO lab Aug 2023
Montelukast Sodium and Levocetirizine Dihydrochloride Tablets IP (Viznil) VNE2101Mfg 2021-06 · Exp 2023-05 DescriptionDescription RDTL GuwahatiState lab Sep 2022

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.